Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention

Cardiology Journal

Volumn 20, Issue 5, 2013, Pages 491-498

  Rechcński, Tomasz ^a   Jasińska, Aleksandra ^a   Foryś, Jakub ^a   Krzemińska Pakula, Maria ^a   Wierzbowska Drabik, Karina ^a   Plewka, Michał ^a   Peruga, Jan Zbigniew ^a   Kasprzak, Jarosław Damian ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Myocardial infarction; Platelets; Prognosis

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PLATELET DISTRIBUTION WIDTH; PLATELET LARGE CELL RATIO; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RETREATMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; THROMBOCYTE FUNCTION AND CHARACTERISTICS; THROMBOCYTE VOLUME;

AGED; BLOOD PLATELETS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885215354     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0134     Document Type: Article

References (23)

1. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med, 1983; 101: 205-213.
2. Isik X, Ayhan E, Uyarel H et al. Increased mean platelet volume associated with extent of slow coronary flow. CardiolJ, 2012; 19: 355-362.
3. Pizzuli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina and non-cardiac chest pain. Eur Heart J, 1998; 19: 80-84.
4. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W Is elevated mean platelet volume associated with a worse outcome in patients with acute ischaemic cerebrovascular events? Stroke, 2004; 35:1688-1691.
5. Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke, 2004; 35: 622-626.
6. Kilicki-Camur N, Demirtunc R, Konuralp C, Eskiser A, Basaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? MedSci Monit, 2005; 11: 387-392.
7. Endler G, Klimesch A, Sunder-Plassmann H et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haemat, 2002; 117: 399-404.
8. Tekbas E, Kara AF, Ariturk Z et al. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest, 2011; 71: 613-619.
9. Huczek Z, Kochman J, Filipiak K et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol, 2005; 46: 284-290.
10. Huczek Z, Filipiak JK, Kochman J et al. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thrombosis Res, 2010; 125: 406-412.
11. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J, 2007; 28: 2525-2538.
12. Jankowska B, Uchmanowicz I, Loboz-Grudzień K, Dudek K. Prevalence of risk factors in patients with acute coronary syndrome (ACS): sex related differences. Pol Przegl Kardiol, 2010; 12: 287-290.
13. Grotto HZ, Noronha JE Platelet large cell ratio (P-LCR) in patients with dyslipidemia. Clin Lab Haem, 2004; 26: 347-349.
14. Tong M, Seth P, Penington DG. Proplatelets and stress platelets. Blood, 1987; 69: 522-528.
15. Martin JF, Daniels TD, Trowbridge EA. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass-induced throm-bocytopenia in man. Thromb Haemost, 1987; 57: 55-58.
16. Marucci R, Gori AM, Paniccia R et al. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting. Thrombosis and Hea-mostasis, 2010:104: 279-286.
17. Thompson CB, Love DG, Quinn PG, Valeri CR. Platelet size does not correlate with platelet age. Blood, 1983; 62: 487-94.
18. Papanas N, Symeonidis G, Maltezos E et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets, 2004; 15: 475-478.
19. Jindal S, Gupta S, Gupta R et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 2011; 16: 86-89.
20. Postula M, Rosiak M, Kaplon-Cieslicka A et al. Do statins influence platelet reactivity on acetylsalicylic acid therapy in patients with type 2 diabetes? CardiolJ, 2012; 19: 494-500.
21. Thompson CB, Diaz DD, Quinn PG, Lapins M, Kurtz SR, Valeri CR. The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol, 1983; 80: 327-332.
22. Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol, 2006; 59:146-149.
23. Guthikonda S, Lev El, Patel R et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost, 2007; 5: 490-496.